Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion

H. C. Diener, R. Bernstein, K. Butcher, B. Campbell, G. Cloud, A. Davalos, S. Davis, J. M. Ferro, M. Grond, D. Krieger, G. Ntaios, A. Slowik, E. Touzé

Research output: Contribution to journalArticleOtherpeer-review

42 Citations (Scopus)

Abstract

Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed by rt-PA and/or thrombectomy in patients with ischemic stroke pre-treated with dabigatran. The use of idarucizumab followed by rt-PA is covered by the label of both drugs.

Original languageEnglish
Pages (from-to)9-12
Number of pages4
JournalInternational Journal of Stroke
Volume12
Issue number1
DOIs
Publication statusPublished - 1 Jan 2017
Externally publishedYes

Keywords

  • dabigatran
  • idarucizumab
  • Ischemic stroke
  • rt-PA
  • thrombectomy
  • thrombolysis

Cite this